Sigmas Group
North America, New York, United States, New York
Description
Sigmas Group
Investor Profile
Sigmas Group has backed more than 7 startups, with 2 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series B, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Artificial Intelligence (AI), Biotechnology.
Stage Focus
- Seed (29%)
- Series B (14%)
- Series D (14%)
- Post Ipo Equity (14%)
- Series Unknown (14%)
- Series C (14%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Artificial Intelligence (Ai)
- Biotechnology
- Analytics
- Management Information Systems
- Medical
- Asset Management
- Pharmaceutical
- Agriculture
- Agtech
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.